What I quoted was from December 4. From the response to price query.
Have you been in Bios before?
IF they have enough data in march to approach the FDA there's pretty much no way that they'll get into the FDA by June. And because the complete data won't be available until 2H 2025 they'd be completely mad to try.
You cant stuff around when approaching the FDA.
You quoted NEU earlier. They spent over 3 months collating data before they even went to the FDA.
Thats obviously why they've gone for a CR. they need working capital.
And then they'll need a partner to pay for PH 3.
If they commence Ph3 by mid 2026 they will have done well. Very well.
SNT Price at posting:
6.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)